Search

everythinglearnresearchcommunity

for

Search:↓

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Human hair follicle cells can be turned into stem cells similar to embryonic stem cells.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Genetic differences affect COVID-19 severity and treatment development.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

The skin and thymus develop similarly to protect and support immunity.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.